Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 5 15 SULFITE FREE IN DEXTROSE 15 IN PLASTIC CONTAINER versus NOVAMINE 15.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 5 15 SULFITE FREE IN DEXTROSE 15 IN PLASTIC CONTAINER versus NOVAMINE 15.
CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER vs NOVAMINE 15%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amino acids provide substrates for protein synthesis and nitrogen balance; dextrose provides caloric support. Electrolytes maintain acid-base and fluid balance.
Amino acids solution providing essential and non-essential amino acids for protein synthesis, tissue repair, and maintenance of nitrogen balance.
Intravenous infusion. Dose individualized based on protein and calorie requirements. Typical adult dose: 500-2000 mL/day, providing 5% amino acids (50 g/L) and 15% dextrose (150 g/L). Infusion rate not to exceed 0.1 g/kg/hour of amino acids.
Intravenous infusion. Adults: 1-2 g/kg/day of amino acids, adjusted based on metabolic needs, clinical status, and nitrogen balance. Typical infusion rate: 100-200 mL/hour of 15% solution (0.15-0.3 g/kg/hour).
None Documented
None Documented
Not applicable as a composite; individual amino acids: 0.5–2 h, dextrose: 1.5–2.5 h. Clinical context: continuous infusion reaches steady state within 4–6 h.
Variable; amino acid half-lives range from minutes to hours depending on individual amino acid. Clinical context: continuous infusion achieves steady state within 24 hours in normal renal function.
Renal excretion of amino acids and dextrose metabolites; 100% eliminated via kidneys as urea, CO2, and water. Biliary/fecal negligible.
Amino acids are metabolized; nitrogen is excreted primarily as urea in urine (80% of nitrogen), with minimal fecal elimination (<5%).
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition